Grant in the Spotlight: Wyss Zurich Translational Center
The Wyss Foundation is excited to announce a CHF (Swiss Franc) 108,000,000 grant to support the Wyss Zurich Translational Center, a leading innovation hub in Switzerland translating research into clinical use and market solutions.
The Wyss Zurich Translational Center is a joint accelerator of the University of Zurich and ETH Zurich (Swiss Federal Institute of Technology Zurich). It was established to foster translational research focused on developing treatment protocols and clinical therapies, as well as novel technologies and intelligent systems, in the emerging fields of regenerative medicine, robotics, and medical devices/bionics technologies. Wyss Zurich unites world-leading experts from both institutions in multidisciplinary teams, pooling their knowledge and expertise.
“We are very grateful for the Wyss Foundation’s support of our translational center for the promotion of startups focusing on highly complex, next-generation clinical therapies and technical solutions. We view this grant as recognition of our work and as an incentive that allows us to support further promising projects and excellent, highly motivated teams,” said Simon P. Hoerstrup, founding co-director of Wyss Zurich.
“After seven years, we can proudly say that Wyss Zurich's acceleration of technology transfer is working very well. Many of the twenty-three Wyss Zurich projects are already successful and have created several hundred new jobs. Support of the Wyss Foundation has a leverage effect for the benefit of society and the economy,” said Roland Siegwart, founding co-director of Wyss Zurich.
----------------------------------------------------------------------------------------
About the Wyss Foundation – The Wyss Foundation is a private, charitable foundation dedicated to supporting innovative, lasting solutions that improve lives, empower communities, and strengthen connections to the land.
About the Wyss Zurich Translation Center – The Wyss Zurich Translational Center’s mission is to drive the translation of outstanding scientific discoveries into new therapies for patients and breakthrough innovations in the fields of regenerative medicine, robotics, and medical devices/bionics technologies.